
Marcef T 1.125mg Injection
Marketer
Mark Remedies Pvt Ltd
Salt Composition
Ceftriaxone (1.125mg)
Overview Marcef T 1.125mg Injection
Ceftizoxime 1.125mg injection, a cephalosporin antibiotic, combats bacterial infections throughout the body. Its applications encompass infections of the central nervous system (meningitis), respiratory system (pneumonia), ears, urinary tract, integumentary system, musculoskeletal system, bloodstream, and cardiovascular system. Prophylactically, it's also used to prevent surgical site infections. Administered intravenously or intramuscularly by a healthcare professional, the dosage is determined individually. Regular, evenly-spaced doses, as directed, are crucial; premature cessation can cause relapse or infection exacerbation. Common adverse reactions include diarrhea, skin rashes, altered liver function test results, and variations in blood cell counts (e.g., eosinophilia, leukopenia, thrombocytopenia). Transient injection site reactions (erythema, pain) may also occur. While usually mild, persistent or bothersome side effects warrant medical attention. Prior to treatment, disclose any antibiotic allergies, hepatic or renal impairment, and all concomitant medications to your physician, as interactions are possible.
Uses of Marcef T 1.125mg Injection
Managing bacterial infections
Major Benefits of Marcef T 1.125mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Marcef T 1.125mg Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Marcef T 1.125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Marcef T 1.125mg Injection works:
Ceftizoxime, administered as a 1.125mg injection, acts as a bactericidal antibiotic. Its mechanism involves disruption of bacterial cell wall synthesis, a process essential for bacterial viability.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Marcef T 1.125mg Injection.
PregnancySAFE IF PRESCRIBED
Cefixime injection (1.125mg) is considered safe for use during gestation. The majority of research indicates minimal or negligible harm to the fetus.
Breast feedingCAUTION
Administering Marcef T 1.125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Marcef T 1.125mg Injection may induce drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneySAFE IF PRESCRIBED
Ceftizoxime injection (1.125 mg) is considered safe for individuals with impaired renal function; dose modification is generally unnecessary. Nevertheless, disclosure of pre-existing kidney conditions to your physician is advised.
LiverCAUTION
Administering Marcef T 1.125mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Marcef T 1.125mg Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Marcef T 1.125mg Injection :
Omitting a dose of Marcef T 1.125mg Injection necessitates contacting your physician.
Facts to Know About Marcef T 1.125mg Injection
| Label | Value |
|---|---|
| Chemical Category | Extended-Spectrum Cephalosporins (Generations 3 & 4) |
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
